Isoplate

Product manufactured by Terumo Bct Ltd.

Application Nr Approved Date Route Status External Links
BN090067 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Isoplate Solution - Platelet Additive Solution [pas-F] Is An Isotonic Solution To Replace A Portion Of The Plasma To Store Platelets Pheresis Platelet Additive Solution (pas) Added Leukocytes Reduced Products Collected Using A Hyperconcentrated Collection On Terumo Bct's Trima Accel System [see Dosage And Administration (2).] Platelets Pheresis Pas Added Leukocytes Reduced Products Are Stored In A Mix Of 65% Isoplate Solution And 35% Plasma. Platelets In The Solution Can Be Stored At A Concentration Range Of 0.7 To 2.1 × 106/µl For Up To 5 Days At 20-24 °c With Continuous Agitation In The Terumo Bct Elp Bag [citrated Polyvinyl Chloride (pvc)] [see Clinical Studies (14).] Isoplate Solution - Platelet Additive Solution [pas-F] Is An Isotonic Solution To Replace A Portion Of The Plasma To Store Platelets Pheresis Platelet Additive Solution (pas) Added Leukocytes Reduced Products Collected Using A Hyperconcentrated Collection On Terumo Bct's Trima Accel System. Platelets Pheresis Pas Added Leukocytes Reduced Products Are Stored In A Mix Of 65% Isoplate And 35% Plasma. Platelets In Isoplate Solution Can Be Stored At A Concentration Range Of 0.7 To 2.1 × 106/µl For Up To 5 Days At 20-24 °c With Continuous Agitation In The Terumo Bct Elp Bag [citrated Polyvinyl Chloride (pvc)]. (1)

All Formulated Excipients (0 Total)

None

Comments